NASDAQ:QNRX
Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. reported net income of −$15.8M in fiscal 2025.Summary generated from Quoin Pharmaceuticals Ltd.'s SEC filings. Latest annual report filed Mar 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−141.6%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | −21 | −9 | −9 | −9 | −16 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- DEF 14AProxy statement
Oct 2, 2026 - 8-KRegulation FD disclosure
Sep 22, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 4Insider transaction report
Sep 1, 2026 - 4Insider transaction report
Sep 1, 2026 - 8-KEntry into a material agreement
Aug 28, 2026 - 8-KDirector or officer change
Aug 20, 2026 - 8-KResults of operations and financial condition
Aug 14, 2026